Pharmacologic Relapse Prevention for Alcoholic Smokers
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study will compare the long-term use of bupropion (Wellbutrin) and placebo for reducing
the rate of smoking relapse in recovering alcoholics who achieved initial abstinence from
smoking with nicotine patch therapy. The study will also determine the cessation rate in the
8th week of treatment among recovering alcoholics using a nicotine patch. The patch dose is
projected to serve as a 100-percent replacement.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)